Laila Nutraceuticals unveils women's wellness platform at World Economic Forum

At Davos, Laila Nutraceuticals unveiled a science-led women's wellness initiative led by Yuthika Gokaraju and publicly supported by Smriti Irani; the platform is rooted in decades of botanical research and aims to offer life-stage preventive care using clinically validated bioactives.

Laila Nutraceuticals announced a science-led women's wellness initiative at the World Economic Forum in Davos. The program was presented by Yuthika Gokaraju, Vice President of Business Development at Laila Nutraceuticals, and received public endorsement from Smriti Irani. The platform is described as an expansion of the company's nearly five decades of botanical research and clinical validation. It is framed as a preventive, life-stage-aligned approach to women's health rather than a single product. Key details: - The initiative pairs patented, clinically validated bioactives with advanced dual-release delivery systems designed for daily usability and consistent absorption. - Areas of focus listed include reproductive and menstrual health, hormonal transitions, metabolic balance, bone and joint health, cognition, mood, and healthy aging. - The company notes its global research infrastructure includes over 150 scientists, more than 20 patented ingredients, cGMP-compliant manufacturing, and partnerships across 25+ countries, alongside a reported investment of about 350 Crores for facility expansion. - The proposal is reported to be co-launched under the regulatory purview of the Food Safety and Standards Authority of India and the Ministry of AYUSH, subject to applicable approvals and ongoing regulatory processes. - Smriti Irani is described in the announcement as an inspiration and evangelist for the platform and congratulated Yuthika Gokaraju at the Davos launch. Summary: The initiative is presented as a platform intended to address structural gaps in women's health by integrating traditional Indian botanical knowledge with modern clinical science. The launch at Davos is positioned alongside India's stated emphasis on evidence-based traditional and preventive healthcare. The announcement notes ongoing regulatory processes and a proposed co-launch under FSSAI and the Ministry of AYUSH.